Anticholinergic Medication Use and Fractures in Postmenopausal Women: Findings from the Women’s Health Initiative

Zachary A. Marcum, Heidi S. Wirtz, Mary Pettinger, Andrea Z. LaCroix, Ryan Carnahan, Jane A. Cauley, Jennifer W Bea, Shelly L. Gray

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: Anticholinergic medication use has been associated with several negative health outcomes in older adults, but little is known about its risk for fractures. Objective: To examine the association between anticholinergic medication use and fracture outcomes in community-dwelling postmenopausal women. Methods: Utilizing a prospective cohort design, we examined data collected from 137,408 women aged 50–79 years from the Women’s Health Initiative observational study and clinical trials not reporting hip fracture at baseline. Medications with moderate or strong anticholinergic effects were identified directly from drug containers during in-person interviews. The main outcome was fractures (hip, lower arm/wrist and total fractures). We performed multivariable Cox proportional hazard survival modelling to assess the association between anticholinergic use and the risk of fractures. Results: At baseline, 10.6 % of the women were using an anticholinergic medication, of which antihistamines were the most common medication class (48.4 %). The multivariable-adjusted hazard ratios for anticholinergic medication use were 1.08 (95 % confidence interval [CI] 0.89–1.30) for hip fracture, 1.01 (95 % CI 0.91–1.13) for lower arm/wrist fracture and 1.03 (95 % CI 0.98–1.09) for total fractures. We observed no association according to subclass or count of anticholinergic medications, or trends between the duration of anticholinergic use and any of the fracture outcomes. Conclusion: Anticholinergic medication use was not associated with an increased risk of fractures among community-dwelling women. Future research should make efforts to capture over-the-counter medication use and the cumulative anticholinergic burden in relation to important health outcomes for older adults.

Original languageEnglish (US)
Pages (from-to)755-763
Number of pages9
JournalDrugs and Aging
Volume32
Issue number9
DOIs
StatePublished - Sep 29 2015

Fingerprint

Cholinergic Antagonists
Women's Health
Hip Fractures
Independent Living
Confidence Intervals
Wrist
Arm
Drug Packaging
Histamine Antagonists
Health
Observational Studies
Clinical Trials
Interviews
Survival

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Geriatrics and Gerontology

Cite this

Marcum, Z. A., Wirtz, H. S., Pettinger, M., LaCroix, A. Z., Carnahan, R., Cauley, J. A., ... Gray, S. L. (2015). Anticholinergic Medication Use and Fractures in Postmenopausal Women: Findings from the Women’s Health Initiative. Drugs and Aging, 32(9), 755-763. https://doi.org/10.1007/s40266-015-0298-1

Anticholinergic Medication Use and Fractures in Postmenopausal Women : Findings from the Women’s Health Initiative. / Marcum, Zachary A.; Wirtz, Heidi S.; Pettinger, Mary; LaCroix, Andrea Z.; Carnahan, Ryan; Cauley, Jane A.; Bea, Jennifer W; Gray, Shelly L.

In: Drugs and Aging, Vol. 32, No. 9, 29.09.2015, p. 755-763.

Research output: Contribution to journalArticle

Marcum, ZA, Wirtz, HS, Pettinger, M, LaCroix, AZ, Carnahan, R, Cauley, JA, Bea, JW & Gray, SL 2015, 'Anticholinergic Medication Use and Fractures in Postmenopausal Women: Findings from the Women’s Health Initiative', Drugs and Aging, vol. 32, no. 9, pp. 755-763. https://doi.org/10.1007/s40266-015-0298-1
Marcum, Zachary A. ; Wirtz, Heidi S. ; Pettinger, Mary ; LaCroix, Andrea Z. ; Carnahan, Ryan ; Cauley, Jane A. ; Bea, Jennifer W ; Gray, Shelly L. / Anticholinergic Medication Use and Fractures in Postmenopausal Women : Findings from the Women’s Health Initiative. In: Drugs and Aging. 2015 ; Vol. 32, No. 9. pp. 755-763.
@article{3fa58354ab664c96a081222a06669300,
title = "Anticholinergic Medication Use and Fractures in Postmenopausal Women: Findings from the Women’s Health Initiative",
abstract = "Background: Anticholinergic medication use has been associated with several negative health outcomes in older adults, but little is known about its risk for fractures. Objective: To examine the association between anticholinergic medication use and fracture outcomes in community-dwelling postmenopausal women. Methods: Utilizing a prospective cohort design, we examined data collected from 137,408 women aged 50–79 years from the Women’s Health Initiative observational study and clinical trials not reporting hip fracture at baseline. Medications with moderate or strong anticholinergic effects were identified directly from drug containers during in-person interviews. The main outcome was fractures (hip, lower arm/wrist and total fractures). We performed multivariable Cox proportional hazard survival modelling to assess the association between anticholinergic use and the risk of fractures. Results: At baseline, 10.6 {\%} of the women were using an anticholinergic medication, of which antihistamines were the most common medication class (48.4 {\%}). The multivariable-adjusted hazard ratios for anticholinergic medication use were 1.08 (95 {\%} confidence interval [CI] 0.89–1.30) for hip fracture, 1.01 (95 {\%} CI 0.91–1.13) for lower arm/wrist fracture and 1.03 (95 {\%} CI 0.98–1.09) for total fractures. We observed no association according to subclass or count of anticholinergic medications, or trends between the duration of anticholinergic use and any of the fracture outcomes. Conclusion: Anticholinergic medication use was not associated with an increased risk of fractures among community-dwelling women. Future research should make efforts to capture over-the-counter medication use and the cumulative anticholinergic burden in relation to important health outcomes for older adults.",
author = "Marcum, {Zachary A.} and Wirtz, {Heidi S.} and Mary Pettinger and LaCroix, {Andrea Z.} and Ryan Carnahan and Cauley, {Jane A.} and Bea, {Jennifer W} and Gray, {Shelly L.}",
year = "2015",
month = "9",
day = "29",
doi = "10.1007/s40266-015-0298-1",
language = "English (US)",
volume = "32",
pages = "755--763",
journal = "Drugs and Aging",
issn = "1170-229X",
publisher = "Adis International Ltd",
number = "9",

}

TY - JOUR

T1 - Anticholinergic Medication Use and Fractures in Postmenopausal Women

T2 - Findings from the Women’s Health Initiative

AU - Marcum, Zachary A.

AU - Wirtz, Heidi S.

AU - Pettinger, Mary

AU - LaCroix, Andrea Z.

AU - Carnahan, Ryan

AU - Cauley, Jane A.

AU - Bea, Jennifer W

AU - Gray, Shelly L.

PY - 2015/9/29

Y1 - 2015/9/29

N2 - Background: Anticholinergic medication use has been associated with several negative health outcomes in older adults, but little is known about its risk for fractures. Objective: To examine the association between anticholinergic medication use and fracture outcomes in community-dwelling postmenopausal women. Methods: Utilizing a prospective cohort design, we examined data collected from 137,408 women aged 50–79 years from the Women’s Health Initiative observational study and clinical trials not reporting hip fracture at baseline. Medications with moderate or strong anticholinergic effects were identified directly from drug containers during in-person interviews. The main outcome was fractures (hip, lower arm/wrist and total fractures). We performed multivariable Cox proportional hazard survival modelling to assess the association between anticholinergic use and the risk of fractures. Results: At baseline, 10.6 % of the women were using an anticholinergic medication, of which antihistamines were the most common medication class (48.4 %). The multivariable-adjusted hazard ratios for anticholinergic medication use were 1.08 (95 % confidence interval [CI] 0.89–1.30) for hip fracture, 1.01 (95 % CI 0.91–1.13) for lower arm/wrist fracture and 1.03 (95 % CI 0.98–1.09) for total fractures. We observed no association according to subclass or count of anticholinergic medications, or trends between the duration of anticholinergic use and any of the fracture outcomes. Conclusion: Anticholinergic medication use was not associated with an increased risk of fractures among community-dwelling women. Future research should make efforts to capture over-the-counter medication use and the cumulative anticholinergic burden in relation to important health outcomes for older adults.

AB - Background: Anticholinergic medication use has been associated with several negative health outcomes in older adults, but little is known about its risk for fractures. Objective: To examine the association between anticholinergic medication use and fracture outcomes in community-dwelling postmenopausal women. Methods: Utilizing a prospective cohort design, we examined data collected from 137,408 women aged 50–79 years from the Women’s Health Initiative observational study and clinical trials not reporting hip fracture at baseline. Medications with moderate or strong anticholinergic effects were identified directly from drug containers during in-person interviews. The main outcome was fractures (hip, lower arm/wrist and total fractures). We performed multivariable Cox proportional hazard survival modelling to assess the association between anticholinergic use and the risk of fractures. Results: At baseline, 10.6 % of the women were using an anticholinergic medication, of which antihistamines were the most common medication class (48.4 %). The multivariable-adjusted hazard ratios for anticholinergic medication use were 1.08 (95 % confidence interval [CI] 0.89–1.30) for hip fracture, 1.01 (95 % CI 0.91–1.13) for lower arm/wrist fracture and 1.03 (95 % CI 0.98–1.09) for total fractures. We observed no association according to subclass or count of anticholinergic medications, or trends between the duration of anticholinergic use and any of the fracture outcomes. Conclusion: Anticholinergic medication use was not associated with an increased risk of fractures among community-dwelling women. Future research should make efforts to capture over-the-counter medication use and the cumulative anticholinergic burden in relation to important health outcomes for older adults.

UR - http://www.scopus.com/inward/record.url?scp=84942500203&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942500203&partnerID=8YFLogxK

U2 - 10.1007/s40266-015-0298-1

DO - 10.1007/s40266-015-0298-1

M3 - Article

C2 - 26373414

AN - SCOPUS:84942500203

VL - 32

SP - 755

EP - 763

JO - Drugs and Aging

JF - Drugs and Aging

SN - 1170-229X

IS - 9

ER -